Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email:  
Bone and Cancer

Clinical Trials

SecreFlo (secretin)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved April 2002

Specific Treatments:

Pancreatic dysfunction and gastrinoma

Therapeutic Areas

General Information

SecreFlo is a synthetic version of the intestinal hormone secretin. This product has been approved by the FDA for use in stimulating pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction. Additionally, SecreFlo is approved for use in stimulating gastrin secretion to aid in the diagnosis of gastrinoma, a tumor usually found in the pancreas.

Clinical Results

Intravenous administration of SecreFlo stimulates the pancreas to secrete pancreatic juice, which can aid in the diagnosis of exocrine pancreatic dysfunction. Three crossover studies evaluated 21 subjects with a history of chronic pancreatitis. In these trials, SecreFlo was compared to biologically derived porcine secretin (bPS). Results demonstrated that all subjects - treated with either drug - had peak bicarbonate concentrations of less than 80 mEq/L, which is consistent with impaired pancreatic function.

Intravenously administered SecreFlo has been shown to stimulate gastrin secretion in patients with gastrinoma; in contrast, secretion is not considerably increased in healthy individuals or those with peptic ulcer disease. Two SecreFlo crossover studies included eight subjects with tissue-confirmed gastrinoma. Subjects received treatment with SecreFlo, and serum gastrin concentrations were compared to those obtained with bPS. Results showed that for both drugs, serum gastrin concentrations exceeded 100 pg/mL from basal levels.

Side Effects

Adverse events noted in clinical trials of SecreFlo include (but are not limited to) the following:

  • Abdominal discomfort
  • Nausea
  • Mild bradycardia (reduced heart rate)
  • Decreased blood pressure
  • Diaphoresis (profuse perspiration)

Mechanism of Action

SecreFlo (secretin) is a pure sterile, non-pyrogenic, lypholized white cake powder acetate salt of secretin, a peptide hormone. The primary action of SecreFlo is to increase the volume and bicarbonate content of secreted pancreatic juices. (from SecreFlo FDA Label)

Additional Information

For additional information on SecreFlo, please visit the Repligen company web site.

 How To Order Publications:

Information About

Clinical Trials



















  Copyright 2011 - The Bone and Cancer Foundation